Zanzibar Malaria Elimination Programme Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2016
NCT02721186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Zanzibar Malaria Elimination Programme

Active Ingredients

Drugs in Phase 4 Trials (3)

amodiaquine (camoquin) (1 trial)

artesunate (1 trial)

primaquine (2 trials)

Drugs in Other Trials (2)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5